DYRK3 and ovarian carcinoma: Additionally, Matrigel-Transwell assays demonstrated impaired invasion capacities in both cell lines upon DYRK3 knockdown (Figures 4(c) and 4(d)), suggesting a potential regulatory role of DYRK3 in the invasive behavior of ovarian cancer cells.